ArticleHeliyon2024

SLC8A1, a novel prognostic biomarker and immunotherapy target in RSA and UCEC based on scRNA-seq and pan-cancer analysis.

Ji-Jun Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.